Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract

NCT00721968 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2014-03-06

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 in conjunction with cataract surgery, compared to cataract surgery only, in subjects with mild to moderate open angle glaucoma.

Conditions

  • Open-angle Glaucoma

Interventions

DEVICE

Glaucoma Stent Surgery (GTS400 Stent)

ab interno trabecular bypass stent surgery

PROCEDURE

cataract surgery alone

Cataract surgery alone

Sponsors & Collaborators

  • Glaukos Corporation

    lead INDUSTRY

Principal Investigators

  • Head of Clinical Affairs · Glaukos Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2012-02-29
Completion
2012-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00721968 on ClinicalTrials.gov